Skip to main content

Table 2 Human cell lines originated from ovarian cancer or human ovarian surface epithelium

From: Reliable in vitro studies require appropriate ovarian cancer cell lines

ID number

Cell line

Origin

Source

Homo sapiens– human

1

222

  

2

2008

Ovary

 

3

2008/C13.R

Ovarian adenocarcinoma

NCBI

4

41Ma/OAW28

Ovarian cancer ascites

ECACC

5

41 M cisR

Ovarian cancer ascites

 

6

59 M

Ovarian cancer ascites

ECACC

7

A2780

Ovarian adenocarcinoma

ECACC

8

A2780ADR

Ovarian adenocarcinoma; A2780

ECACC

9

A2780cis

Ovarian adenocarcinoma; A2780

ECACC

10

A2780 CP

Ovarian adenocarcinoma

NCBI

11

A2780 S

Ovarian adenocarcinoma

NCBI

12

Caov-3

Ovarian adenocarcinoma

ATCC

13

Caov-4

Metastatic fallopian tube mass from ovarian tumour

ATCC/NCBI

14

CH1

Ovarian adenocarcinoma

 

15

CH1cisR

Ovarian adenocarcinoma

 

16

COLO-704

Metastatic colonic ascites from ovarian tumour

DSMZ

17

COV318

Ovarian cancer ascites

ECACC

18

COV362

Ovarian cancer pleural effusion

ECACC

19

COV362.4

Ovarian cancer pleural effusion; COV362

ECACC

20

COV413A

Metastatic sigmoid mass from ovarian tumour

ECACC

21

COV413B

Metastatic bladder dome mass from ovarian tumour

ECACC

22

COV434

Ovarian granulosa tumour from a solid primary tumour

ECACC

23

COV504

Ovarian pleural effusion

ECACC

24

COV644

Ovarian cancer (primary tumor)

ECACC

25

EFO-21

Ovarian cancer ascites

DSMZ

26

EFO27

Metastatic omental mass from ovarian tumour

DSMZ

27

ES-2

Ovarian adenocarcinoma

ATCC

28

FU-OV-1

Malignant ovarian mass

DSMZ

29

HAC-2

Ovarian cancer cell derived from mesonephros

JCRB

30

Hey-A8

Ovary

CCLE

31

HOSE 6-3

Ovarian surface epithelium

 

32

HOSE 17-1

Ovarian surface epithelium

 

33

HOSE 105

Ovarian surface epithelium

 

34

HOSE 111

Ovarian surface epithelium

 

35

HOSE 129

Ovarian surface epithelium

 

36

HOSE 130

Ovarian surface epithelium

 

37

Hs 38.T

Ovarian teratoma

ATCC

38

Hs 571.T

Ovarian adenocarcinoma

ATCC

39

Hs904.T

  

40

IGROV1

Ovarian adenocarcinoma

 

41

JHOC-5

Ovarian adenocarcinoma

CCLE

42

JHOM-1

Ovarian adenocarcinoma

CCLE

43

JHOM-2B

Ovarian adenocarcinoma

CCLE

44

JHOS-2

Ovarian adenocarcinoma

CCLE

45

JHOS-4

Ovarian adenocarcinoma

CCLE

46

KURAMOCHI

Ovarian cancer ascites

JCRB

47

MCAS

Ovarian adenocarcinoma

JCRB

48

NCC-OvC-K119

Ovarian adenocarcinoma

JCRB

49

OAW28/41 M

Ovarian cancer ascites

ECACC

50

OAW42

Ovarian cancer ascites

ECACC

51

OC 314

Ovarian cancer ascites

CCLE

52

OC 315

Ovarian adenocarcinoma

CCLE

53

OC 316

Ovarian cancer ascites

CCLE

54

ONCO-DG-1a

Ovarian adenocarcinoma

DSMZ

55

OV-7

Ovarian adenocarcinoma derived from solid tumour

ECACC

56

OV17R

Ovarian cancer ascites

ECACC

57

OV56

Ovarian cancer ascites

ECACC

58

OV-58

Ovarian cancer ascites

ECACC

59

OV-90

Ovarian cancer ascites

ATCC

60

OV-1063a

  

61

OVC1-PI 32

Ovary

NCBI

62

OVCAR-3

Ovarian cancer ascites

ATCC/NCBI

63

OVCAR-4

Ovarian adenocarcinoma

CCLE

64

OVCAR-8

Ovarian adenocarcinoma

CCLE

65

OVISE

Metastatic ovarian adenocarcinoma

JCRB/CCLE

66

OVK18

Ovarian adenocarcinoma

CCLE

67

OVKATE

Ovarian adenocarcinoma

JCRB

68

OVMANA

Ovarian adenocarcinoma

JCRB

69

OVMIUa

Ovarian adenocarcinoma

JCRB

70

OVMIU-IIa

Ovarian adenocarcinoma

JCRB

71

OVSAHO

Ovarian adenocarcinoma

JCRB

72

OVSAYOa

Ovarian adenocarcinoma

JCRB

73

OVTOKO

Ovarian adenocarcinoma

JCRB

74

PA-1

Ovarian cancer ascites

ATCC/JCRB/ECACC

75

PA-1/6TG-r

Ovarian cancer ascites

JCRB

76

PEA1

Ovarian cancer pleural effusion

ECACC

77

PEA2

Ovarian cancer ascites

ECACC

78

PEO1

Ovarian cancer ascites

ECACC

79

PEO4

Ovarian cancer pleural effusion

ECACC

80

PEO6

Ovarian cancer ascites

ECACC

81

PEO14b

Ovarian cancer ascites

ECACC

82

PEO16

Ovarian cancer ascites

ECACC

83

PEO23b

Ovarian cancer ascites

ECACC

84

RKN

Ovarian adenocarcinoma

JCRB

85

RMG-Ia

Ovarian adenocarcinoma

JCRB

86

RMG-II

Ovarian adenocarcinoma

JCRB

87

RMUG-La

Ovarian adenocarcinoma

JCRB

88

RMUG-S

Ovarian adenocarcinoma

JCRB

89

RTSGc

Ovarian adenocarcinoma

JCRB

90

SCC60

  

91

SK-OV-3

Ovarian cancer ascites

ATCC/NCBI/ECACC

92

SNU-8

Ovarian adenocarcinoma

CCLE

93

SNU-119

Ovarian adenocarcinoma

CCLE

94

SNU-840

Ovarian adenocarcinoma

CCLE

95

SW 626

Ovarian metastatic mass from colon tumour

ATCC/ECACC

96

TE 84.T

Ovarian adenocarcinoma

ATCC

97

TO14b

Metastatic omental mass from ovarian tumour

ECACC

98

TOV-21G

Malignant ovarian mass

ATCC

99

TOV-81D

Malignant ovarian mass

 

100

TOV-112D

Malignant ovarian mass

ATCC

101

TYK-nu

Ovarian adenocarcinoma

JCRB

102

TYK-nu.CP-r

Ovarian adenocarcinoma

JCRB

103

UC1-101

Ovarian adenocarcinoma

 

104

UC1-107

  
  1. aPossible cross contamination or misidentification (JCRB, DSMZ: Database of Cross-Contaminated or misidentified cell lines, Capes-Davis, A. and Freshney, R.I. Version 6.7, Table 1 27.6.2011). Cross contaminated with OVCAR-3 (ONCO-DG-1); bAll these cell lines were derived from the same patient.